ReviewHuman vaccines & immunotherapeutics2026

Mosunetuzumab: A bispecific CD20 × CD3 antibody for follicular lymphoma with promising evidence in other B-NHL subtypes.

Geoffrey ShousePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.